MedPath

Investigating the effect of increasing awareness based on Acceptance and Commitment Therapy on the quality of life of women with HPV

Not Applicable
Recruiting
Conditions
Human papilloma virus (HPV) infection.
Cervical high risk human papillomavirus (HPV) DNA test positive
R87.810
Registration Number
IRCT20170611034452N16
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Positive HPV test confirmed by gynecological oncology specialist
Less than 6 months have passed since the positive test result
Willingness to participate in the study and complete the informed consent form
Not having any neurological or mental illness
Not suffering from the type Another sexually transmitted disease
Being sexually active

Exclusion Criteria

Getting HPV-related cancer while studying
Getting pregnant while studying
If you miss more than one session and don't do your homework

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of Life. Timepoint: The first session of the intervention and 2 weeks after the completion of the intervention sessions. Method of measurement: Quality of life questionnaire (EQUALI-HPV).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath